Trexquant Investment LP Buys 57,652 Shares of Privia Health Group, Inc. $PRVA

Key Points

• Trexquant Investment LP increased its stake in Privia Health Group by 65.5% during the first quarter, bringing its total ownership to around 0.12% of the company valued at $3.27 million.
• Privia Health Group reported $0.02 earnings per share for the last quarter, missing estimates by ($0.03), despite revenues hitting $521.15 million—23.4% higher year-over-year.
• Analysts have given Privia Health a consensus rating of "Moderate Buy" with a price target of approximately $28.08, reflecting positive sentiment from multiple investment firms.

Trexquant Investment LP increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 65.5% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 145,641 shares of the company's stock after purchasing an additional 57,652 shares during the quarter. Trexquant Investment LP owned 0.12% of Privia Health Group worth $3,270,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Dimensional Fund Advisors LP increased its position in shares of Privia Health Group by 10.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock worth $27,687,000 after purchasing an additional 138,747 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Privia Health Group by 15.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 73,416 shares of the company's stock valued at $1,436,000 after purchasing an additional 9,880 shares during the period. Northern Trust Corp increased its stake in Privia Health Group by 14.2% during the 4th quarter. Northern Trust Corp now owns 1,392,641 shares of the company's stock worth $27,226,000 after acquiring an additional 173,563 shares during the period. Alyeska Investment Group L.P. raised its stake in Privia Health Group by 20.0% in the fourth quarter. Alyeska Investment Group L.P. now owns 300,000 shares of the company's stock valued at $5,865,000 after purchasing an additional 50,000 shares in the last quarter. Finally, Algert Global LLC lifted its holdings in shares of Privia Health Group by 639.1% during the 4th quarter. Algert Global LLC now owns 108,048 shares of the company's stock worth $2,112,000 after acquiring an additional 93,429 shares during the period. Institutional investors own 94.48% of the company's stock.

Wall Street Analysts Forecast Growth

PRVA has been the topic of a number of analyst reports. Evercore ISI reduced their price target on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 9th. Zacks Research upgraded shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 19th. Citigroup reiterated an "outperform" rating on shares of Privia Health Group in a research note on Friday, August 29th. Barclays upped their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "equal weight" rating in a report on Tuesday, May 27th. Finally, JPMorgan Chase & Co. lifted their price target on Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $28.58.

Privia Health Group Stock Up 1.7%

Shares of NASDAQ:PRVA traded up $0.39 on Monday, hitting $23.67. 154,082 shares of the company traded hands, compared to its average volume of 835,426. The company has a market cap of $2.90 billion, a PE ratio of 216.57, a PEG ratio of 3.37 and a beta of 0.82. Privia Health Group, Inc. has a 52 week low of $16.47 and a 52 week high of $26.09. The stock has a 50 day simple moving average of $21.04 and a 200-day simple moving average of $22.56.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The company had revenue of $521.15 million for the quarter, compared to analysts' expectations of $466.97 million. During the same quarter in the prior year, the firm posted $0.19 earnings per share. Privia Health Group's quarterly revenue was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. As a group, sell-side analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.